| Literature DB >> 32654763 |
Joseph G Pressey1, Christopher E Dandoy2, Luke E Pater3, Julie Sroga Rios4, Rebecca Sisson5, Roshni Dasgupta6, Sara Szabo7.
Abstract
SCCOHT is an aggressive malignancy linked to alterations of SMARCA4. We describe the diagnosis and therapy of a 32 year old who received multi-agent chemotherapy and underwent a second look operation with HIPEC followed by high-dose chemotherapy with stem cell transplant. Supportive care, oncofertility, and genetic counseling are described.Entities:
Keywords: AYA; Ovarian; Rhabdoid; SCCOHT; SMARCA4; Transplant
Mesh:
Substances:
Year: 2020 PMID: 32654763 DOI: 10.1016/j.ygyno.2020.06.160
Source DB: PubMed Journal: Gynecol Oncol ISSN: 0090-8258 Impact factor: 5.482